Transaction #25861 · Form 4 · 0002039294-25-000008
Century Therapeutics, Inc. · Purchase · Common Stock
Century Therapeutics, Inc. · Transacted December 22, 2025 · Filed December 29, 2025
What does this filing report?
An SEC Form 4 filing for Century Therapeutics, Inc. records a purchase involving Common Stock on December 22, 2025. The reported quantity was 58,060. The filing date is December 29, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Century Therapeutics, Inc.
- Company CIK
- 0001850119
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 58,060
- Reported price
- 0.8483
- Reference value
- 49,252.298
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 1,045,087
- Ownership description
- Not reported
- SEC acceptance time
- Dec 29, 2025, 4:52 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Cowan Chad ↗
Chief Scientific Officer
CIK 0002039294
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- All profits from the reported transactions will be disgorged to the issuer pursuant to applicable requirements.
- F2
- Shares held by the Cowan Investment Nominee Trust. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.